Unlocking the healing power of psilocybin: an overview of the role of psilocybin therapy in major depressive disorder, obsessive-compulsive disorder and substance use disorder
Frontiers in Psychiatry June 11, 2024 Sandra Szafoni, Piotr Gręblowski, Klaudia Grabowska et al. 12 citations
Psilocybin, a psychedelic substance, is being tested in clinical trials as an adjunct to psychotherapy for patients with major depressive disorder, obsessive-compulsive disorder, and substance use disorders (alcohol and nicotine dependence) that are resistant to traditional treatments. This article reviews current understanding of psilocybin, including data from clinical trials, its mechanism of action, safety profile, and associated risks.